Congratulations to our very own @Jake_Hogan_ already making waves in #ASTRO25 as recipient of the 2025 ARRO Health Care Access Publication Award for his study, “Radiotherapy Utilization in Traditional Medicare and Medicare Advantage” published in JAMA Network Open. Amazing work!!
Thank you @QuadShotNews for providing a excellent review of our @WashURadOnc Sim Free RT experience, a emerging treatment paradigm for patients reviewing palliative radiotherapy ☢️
All-star @WashURadOnc and #Astro22 travel award winner @Barnes_J_M nailed it! Presenting on how federal poverty level confounds/affects Medicaid outcomes data in Cancer patients
I know this personally. The financial burden of cancer has toxic effects on THE WHOLE FAMILY.
When a loved one has cancer, family members are more likely to delayed or forego care due to #financialToxicity; #AYACM#AYA families have the biggest risk.
📰https://t.co/RsGxu0VTcJ
Reminder: Join ACRO & ROVER on 7/15 for a case-based discussion on various aspects of challenging or grey zone cases in oligometastatic disease. This webinar is designed for residents & med students, but all are welcome! Register: https://t.co/42aDXvplHS
Pre-proof @sciencedirect Red Journal:
"Decreases in Radiation Oncology Medicare Reimbursement over time: Analysis by Billing Code"
Written by @WUSTLmed student Jacob Hogan & @BrianBaumannMD this study shows declining reimbursement, esp for advanced tx
https://t.co/S63jsE8HP2
Excited to work with Dr. Amit Roy and @WashURadOnc on "Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis." see the preprint here: https://t.co/JJw7JwMFvt #radonc